Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis

< Back to Listing

Share this Article

Singapore Med J 2014; 55(1): e7-e8; http://dx.doi.org/10.11622/smedj.2013187
Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis

  • Abstract
  • PDF
  • References

Karanth SS, Gupta A, Prabhu MM
Correspondence: Dr Suman S Karanth, drsumansk@gmail.com


ABSTRACT
Hydroxyurea is an antineoplastic agent commonly used to treat essential thrombocytosis. We report the case of a 50-year-old woman who was incidentally detected to have essential thrombocytosis after suffering an episode of cerebrovascular accident with faciobrachial monoparesis. She was subsequently initiated on hydroxyurea. Within seven weeks of therapy, the patient noticed irregular hyperpigmented patches over her feet, hands and perioral region, with bluish-grey longitudinal bands on all 20 nails. Hydroxyurea-induced hyperpigmentation and melanonychia are not commonly reported. To the best of our knowledge, this is only the third published report of hydroxyurea-induced hyperpigmentation and melanonychia involving all 20 nails. Physicians need to be aware of such mucocutaneous side effects to avoid misdiagnosis and unwarranted fear in patients. The decision to discontinue the intake of the drug depends heavily on the future risk of thrombotic events.

Keywords: 
essential thrombocytosis, hydroxyurea, hyperpigmentation, melanonychia
Singapore Med J 2014; 55(1): e7-e8; http://dx.doi.org/10.11622/smedj.2013187

http://smj.org.sg/sites/default/files/5501/5501cr3.pdf

REFERENCES

1. Aste N, Fumo G, Contu F, Aste N, Biggio P. Nail pigmentation caused by hydroxyurea: report of 9 cases. J Am Acad Dermatol 2002; 47:146-7.
http://dx.doi.org/10.1067/mjd.2002.120910
 
2. Laughon SK, Shinn LL, Nunley JR. Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient. Int J Dermatol 2000; 39:926-41.
http://dx.doi.org/10.1046/j.1365-4362.2000.00988-2.x
 
3. Vomvouras S, Pakula AS, Shaw JM. Multiple pigmented nail bands during hydroxyurea therapy: an uncommon finding. J Am Acad Dermatol 1991; 24:1016 - 7.
http://dx.doi.org/10.1016/S0190-9622(08)80119-3
 
4. Teo RY, Tan E. A case of hydroxyurea-induced transverse melanonychia. Int J Dermatol 2006; 45:1329-30.
http://dx.doi.org/10.1111/j.1365-4632.2006.02709.x
 
5. Delmas-Marsalet B, Beaulieu P, Teillet-Thiebaud F, Jary L, Teillet F. Longitudinal melanonychia induced by hydroxyurea: four case reports and review of literature. Nouv Rev Fr Hematol 1995; 37:205-10.
 
6. Cakir B, Sucak G, Haznedar R. Longitudinal pigmented nail bands during hydroxyurea therapy. Int J Dermatol 1997; 36:236-7.
http://dx.doi.org/10.1111/j.1365-4362.1997.tb04194.x
 
7. Gropper CA, Don PC, Sajadi MM. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera. Int J Dermatol 1993; 32:731-3.
http://dx.doi.org/10.1111/j.1365-4362.1993.tb02745.x
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.